𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targets in Fibrotic Disorders

✍ Scribed by R. J. Kok

Publisher
Springer US
Year
2008
Tongue
English
Weight
74 KB
Volume
25
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapeutic targets in cardiovascular di
Therapeutic targets in cardiovascular disorders
✍ Wolfgang Schaper; Wulf D Ito πŸ“‚ Article πŸ“… 1996 πŸ› Elsevier Science 🌐 English βš– 574 KB

The feasibility of gene therapy for cardiovascular diseases related to atherosclerosis is a topic that needs to be addressed. Most recent papers have dealt with technical aspects and feasibility and most of the genes transferred were reporter genes like those for 13-galactosidase or luciferase. This

Defining targets in myeloproliferative d
Defining targets in myeloproliferative disorders: reflecting on what is important
✍ Martin Griesshammer πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 95 KB

## Abstract The current lack of curative options for essential thrombocythaemia (ET) leads to the goal of reducing the risk of potentially life‐threatening thrombohaemorrhagic complications with long‐term treatment. The setting of relevant treatment targets is an important consideration in this pro

Molecular Targeting of Pancreatic Disord
Molecular Targeting of Pancreatic Disorders
✍ Kiichi Tamada; Xiao-Ping Wang; F. Charles Brunicardi πŸ“‚ Article πŸ“… 2005 πŸ› Springer 🌐 English βš– 125 KB
Long-Term Electrical Inhibition of Deep
Long-Term Electrical Inhibition of Deep Brain Targets in Movement Disorders
✍ A. L. Benabid; A. Benazzouz; D. Hoffmann; P. Limousin; P. Krack; P. Pollak πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 582 KB

Stimulation of the thalamic nucleus ventralis intermedius (Vim) at high (130-Hz) frequency has been used over the last 8 years as a treatment in 134 patients with movement disorders (91 Parkinson's disease [PD], 23 essential tremor [ET], 21 various dyskinesias and dystonias, including four multiple